WHO resumes hydroxychloroquine trials for treatment of Covid-19

Source : 112 Ukraine

The commission did not find any evidence of increase in mortality when using the drug to combat the disease
23:31, 3 June 2020


The World Health Organization has resumed clinical trials of hydroxychloroquine for treatment of coronavirus infection. WHO Director-General Tedros Adan Ghebrejesus said so, as CNBC reports.

Related: Ukrainian Railways returned almost $5 million to passengers for canceled trips due to lockdown

“The Data Security Monitoring Council decided that there is no reason to end the international trial after reviewing the available data on the drug,” Ghebrejsus said.

As we reported before, American scientists have concluded that the anti-malarial hydroxychloroquine used in the treatment of Covid-19 increased the risk of death among patients.

"Patients who were taken to a hospital with Covid-19 and were treated with antimalarial hydroxychloroquine were at a higher risk of death than those who did not take it," the study said.

On June 3, the World Health Organization (WHO) claimed it saw a gradual stabilization of the coronavirus situation in some countries. Ukraine was one of them.

Related: His passport has no Russian-language page: Who is Ukraine’s Language Ombudsman candidate Svyatoslav Litynsky?



Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more